Physician profile
Hort Seng
NPI 1093752636
$2,315.52
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,815 · 2020: $405 · 2021: $33.43 · 2022: $62.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $689.58 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $502.17 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $452.97 | 2019-2021 | |
| Amarin Pharma, INC. | $170.20 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $102.01 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.64 | 2019-2022 | |
| Amgen INC. | $84.25 | 2019 | |
| Pfizer INC. | $55.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.84 | 2019-2020 | |
| Esperion Therapeutics, INC. | $22.31 | 2021 | |
| Abbvie INC. | $21.00 | 2020 | |
| Scilex Pharmaceuticals INC. | $15.78 | 2022 | |
| Silk Road Medical, INC. | $15.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.26 | 2019 | |
| Sanofi Pasteur INC. | $14.71 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.67 | 2019 | |
| Hikma Pharmaceuticals USA | $11.76 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hort Seng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.